Related Experiment Video
Updated: Jun 20, 2026
06:47
Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
Published on: September 20, 2011
37.4K
Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future
Gaurav Sinsinbar1, Anivind Kaur Bindra1, Shaoqiong Liu1
1ACM Biolabs Pte Ltd., 71 Nanyang Drive, #02M-02, NTU Innovation Center, Singapore 638075, Singapore.
Biomacromolecules
|January 19, 2024
Summary
Polymersomes, a type of nanoformulation, offer promising drug delivery but require further development for commercialization. Addressing current limitations will enable advanced targeted and sustained delivery of active pharmaceutical ingredients (APIs).
Area of Science:
- Nanotechnology
- Polymer Science
- Pharmaceutical Sciences
Background:
- Nanoformulation aims for targeted, sustained, and effective delivery of active pharmaceutical ingredients (APIs).
- Loading and delivering APIs faces challenges due to their inherent chemical and structural properties.
- Lipid-based systems have limitations in API delivery.
Purpose of the Study:
- To highlight the potential of polymersomes as a tunable API delivery platform.
- To discuss the advantages of polymersomes over lipid-based systems.
- To identify limitations and areas for development in polymersome technology for commercialization.
Main Methods:
- Review of existing literature on polymersomes and API delivery.
- Analysis of the properties of amphiphilic block copolymers (ABCPs) in nanoformulation.
- Case study of a COVID booster vaccine (ACM-001) utilizing polymersomes.
Main Results:
- Polymersomes demonstrate significant promise as a versatile API delivery platform.
- Polymersomes offer advantages over traditional lipid-based delivery systems.
- A COVID booster vaccine using polymersomes has successfully completed Phase I clinical trials.
Conclusions:
- Further development is needed to overcome limitations in polymersome technology.
- Addressing these limitations is crucial for translating polymersome-based delivery from concept to commercial product.
- Polymersomes represent a viable future for advanced drug delivery systems.
Related Concept Videos
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...